Plasma nitric oxide levels used as an indicator of doxorubicin-induced cardiotoxicity in rats

Hematology Journal

Volumn 5, Issue 7, 2005, Pages 584-588

  Guerra, Jhon ^a   De Jesus, Ana ^a   Santiago Borrero, Pedro ^a   Roman Franco, Angel ^a   Rodríguez, Edwin ^a   Crespo, Maria J ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Biomarker; Cardiomyopathy; Doxorubicin; Ejection fraction; Nitric oxide

Indexed keywords

BIOCHEMICAL MARKER; DOXORUBICIN; NITRIC OXIDE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CARDIOTOXICITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; HEART EJECTION FRACTION; HEART INJURY; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; MALE; MICROSCOPY; NON INVASIVE MEASUREMENT; NONHUMAN; RAT; RELIABILITY; SCORING SYSTEM; SENSITIVITY ANALYSIS; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLE;

ANIMALS; BIOLOGICAL MARKERS; DOXORUBICIN; ECHOCARDIOGRAPHY; HEART; MALE; MODELS, ANIMAL; MYOCARDIUM; NITRIC OXIDE; RATS; RATS, INBRED SHR; SYSTOLE;

EID: 14644401796     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200573     Document Type: Article

References (26)

1. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. New Engl J Med 1998; 339: 900-905.
2. Dalledonne L, Milzani A, Colombo R. DXR depresses the alpha-actinin-induced formation of actin bundles. Cancer Biochem Byophys 1993; 13: 245-254.
3. Quiles JL, Huertas JR, Battino M, Mataix J, Ramirez-Tortosa MC. Antioxidant nutrients and adriamycin toxicity. Toxicology 2002; 180: 79-95.
4. Venditti P, Balestrieri M, De Leo T, Di Meo S. Free radical involvement in doxorubicin-induced electrophysiological alterations in rat papillary muscle fibres. Cardiovasc Res 1998; 38: 695-702.
5. Singal PK, Deally CM, Weinberg LE. Subcellular effects of adriamycin in the heart: a concise review. J Mol Cell Cardiol 1987; 19: 817-828.
6. Weinstein DM, Mihm MJ, Bauer JA. Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J Pharmacol Exp Ther 2000; 294: 396-401.
7. Ganz WI, Sridhar KS, Ganz SS, Gonzalez R, Chakko S, Serafini A. Review of tests for monitoring doxorubicin-induced cardiomyopathy. Oncology 1996; 53: 461-470.
8. Bertinchant JP, Polge A, Juan JM, Oliva-Lauraire MC, Giuliani I, Marty-Double C et al. Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiography and histological findings. Clin Chim Acta 2003; 329: 39-51.
9. Herman EH, Zhang J, Lipshultz SE, Rifai N, Chadwick D, Takeda K et al. Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol 1999; 17: 2237-2243.
10. Kismet E, Varan A, Ayabakan C, Alehan D, Portakal O, Buyukpamukcu M. Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin. Pediatr Blood Cancer 2004; 42: 220-224.
11. Mohan P, Brutsaert DL, Paulus WJ, Sys SU. Myocardial contractile response to nitric oxide and cGMP. Circulation 1996; 93: 1223-1229.
12. Son K, Kim YM. In vivo cisplatin-exposed macrophages increase immunostimulant-induced nitric oxide synthesis for tumor cell killing. Cancer Res 1995; 55: 5524-5527.
13. Bani D, Masini E, Bello MG, Bigazzi M, Sacchi TB. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res 1995; 55: 5272-5275.
14. Vasquez-Vivar J, Martasek P, Hogg N, Masters BS, Pritchard Jr KA, Kalyanaraman B. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry 1997; 36: 11293-11297.
15. Herman EH, el-Hage AN, Ferrans VJ, Ardalan B. Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats. Toxicol Appl Pharmacol 1985; 78: 202-214.
16. Ferrans VJ, Sanchez JA, Herman EH. Pathologic anatomy of animal models of anthracyclin-induced cardiotoxicity. In: Muggia F, Speyer J (eds). Cancer and the Heart. Johns Hopkins University: Baltimore, MD, 1992, p 198.
17. Herman EH, el-Hage A, Ferrans VJ. Protective effect of ICRF-187 on doxorubicin-induced cardiac and renal toxicity in spontaneously hypertensive (SHR) and normotensive (WKY) rats. Toxicol Appl Pharmacol 1988; 92: 42-53.
18. Ikeda Y, Martone M, Gu Y, Hoshijima M, Thor A, Oh SS et al. Altered membrane proteins and permeability correlate with cardiac dysfunction in cardiomyopathic hamsters. Am J Physiol Heart Circ Physiol 2000; 278: H1362-H1370.
19. Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR et al. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 1996; 94: 1109-1117.
20. Kauser K, Sonnenberg D, Diel P, Rubanyi GM. Effect of 17beta-estradiol on cytokine-induced nitric oxide production in rat isolated aorta. Br J Pharmacol 1998; 123: 1089-1096.
21. Billinghan ME. Role of endomyocardial biopsy in diagnosis and treatment of heart disease. In: Silver MD (ed). Cardiovascular Pathology. Churchill Livingstone: New York, NY, 1991, p 1465.
22. Varin R, Mulder P, Richard V, Tamion F, Devaux C, Henry JP et al. Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure: role of nitric oxide, prostanoids, and oxidant stress. Circulation 1999; 99: 2951-2957.
23. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindate PT et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996; 93: 1087-1094.
24. Sayed-Ahmed MM, Khattab MM, Gad MZ, Osman AM. Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy. Pharmacol Toxicol 2001; 89: 140-144.
25. Aldieri E, Bergandi L, Riganti C, Costamagna C, Bosia A, Ghigo D. Doxorubicin induces an increase of nitric oxide synthesis in rat cardiac cells that is inhibited by iron supplementation. Toxicol Appl Pharmacol 2002; 185: 85-90.
26. Fadillioglu E, Yilmaz HR, Erdogan H, Sogut S. The activities of tissue xanthine oxidase and adenosine deaminase and the levels of hidroxyproline and nitric oxide in rat hearts subjected to doxorubicin: protective effect of erdosteine. Toxicology 2003; 191: 153-158.